Evidence map›Paper›PMID 32942283›Full record

ArticlePublic health genomics2020

Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.

Ridgely Fisk Green, Marie T Kumerow, Juan L Rodriguez, Siobhan Addie, Sarah H Beachy, Laura Senier

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Public health genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ridgely Fisk GreenCarter Consulting, Inc. and Office of Genomics and Precision Public Health, Office of Science, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, grf1@cdc.gov.
Marie T KumerowDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Juan L RodriguezDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Siobhan AddieNational Academies of Sciences, Engineering, and Medicine, Washington, District of Columbia, USA.
Sarah H BeachyNational Academies of Sciences, Engineering, and Medicine, Washington, District of Columbia, USA.
Laura SenierDepartment of Sociology & Anthropology and Department of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
Centers for Disease Control and Prevention · USNational Academies of Sciences, Engineering, and Medicine · USNortheastern University · US

Funding

Barriers in Translating Genomic Research into State Public Health ProgramsK01HG006441 · NHGRI · UNIVERSITY OF WISCONSIN-MADISON · PI SENIER, LAURA · 2012 to 2016
$885k
Intramural CDC HHS CC999999NHGRI NIH HHS K01 HG006441
6 · The paper itself

Abstract

objectiveTo show how state health agencies can plan and evaluate activities to strengthen the evidence base for public health genomics, we mapped state cancer genomics activities to the Doyle et al. [Genet Med. 2018;20(9):995-1003] implementation science outcome framework.

methodsWe identified state health agency activities addressing hereditary breast and ovarian cancer and Lynch syndrome by reviewing project narratives from Centers for Disease Control and Prevention Cancer Genomics Program funding recipients, leading discussions with state health agencies, and conducting an environmental scan.

resultsState health agencies' cancer genomics activities included developing or adding to state surveillance systems, developing educational materials, bidirectional reporting, promoting health plan policy change, training providers, and promoting recommendations and standards. To address health disparities, programs have tracked group differences, developed culturally appropriate educational materials, and promoted access to services for underserved populations.

conclusionState health agencies can use the Doyle et al. [Genet Med. 2018;20(9):995-1003] performance objectives and outcome measures to evaluate proposed and ongoing activities. By demonstrating whether activities result in improved outcomes, state health agencies can build the evidence for the implementation of cancer genomics activities.

Indexed as

GenomicsImplementation SciencePublic HealthCenters for Disease Control and Prevention, U.S.Colorectal Neoplasms, Hereditary NonpolyposisGenome, HumanHealthcare DisparitiesHealth PolicyHealth Status DisparitiesHumansUnited StatesEvaluationHereditary breast and ovarian cancerImplementationLynch syndromeState health agency

Identifiers

PMID32942283
PMCPMC7855400
OpenAlexW3087705820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.